The Prognostic Implication of the BRAF V600E Mutation in Papillary Thyroid Cancer in a Chinese Population

Figure 1

Kaplan–Meier survival analysis of disease recurrence-free survival of patients with PTC (a) and CPTC (b), stratified by BRAF V600E status.

(a)

(b)